Rome, January 8, 2024: In a move that is likely to reignite the ethical debate surrounding assisted reproduction, Pope Francis has called for a global ban on surrogacy. Delivering his annual address to diplomats accredited to the Holy See, the 87-year-old pontiff declared the practice “deplorable” and a “grave violation of the dignity of the woman and the child.”
The Pope’s remarks came within the context of a broader message highlighting the path to peace and respect for life. He emphasized the sanctity of unborn life and its protection from potential exploitation and commercialization. He specifically focused on surrogacy, arguing that it exploits vulnerable women in need and reduces children to commodities in a contractual process.
“A child is always a gift and never the basis of a commercial contract,” he declared, urging the international community to “prohibit this practice universally.” This marks a continuation of his stance against surrogacy, previously condemned as “inhuman” in June 2022.
It’s important to note that surrogacy practices vary dramatically across the globe. While it remains illegal in many countries, including Italy, others permit “altruistic” surrogacy, where no financial compensation is exchanged beyond covering expenses. This form is legal in nations like the UK, Canada, and parts of the US. Commercial surrogacy, where surrogate mothers receive payment, is also allowed in some American states.
The Pope’s call for a global ban is likely to face significant opposition from proponents of surrogacy who argue it offers hope and fulfillment to individuals and couples struggling with infertility. The ethical and legal complexities surrounding the practice are sure to remain an ongoing point of discussion and debate.
This rewrite offers a more neutral and informative tone, highlighting the Pope’s stance while acknowledging the different perspectives and legal regulations surrounding surrogacy practices worldwide. It also provides context and clarity by explaining the concept of “altruistic” and commercial surrogacy.